Experience of onabotulinumtoxinA (Botox) treatment for overactive bladder in outpatient clinic with less number of injections

Experience of onabotulinumtoxinA (Botox) treatment for overactive bladder in outpatient clinic with less number of injections

Bibliographic Details
Main Authors:	A.K. Habib, D. Feflea, H. Ecclestone, R. Kavia
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320327506

Similar Items

OnabotulinumtoxinA for the treatment of overactive bladder
by: Cox L, et al.
Published: (2014-07-01)

Does the setting for intradetrusor onabotulinumtoxinA injection for management of overactive bladder matter?
by: James H. Ross, et al.
Published: (2024-04-01)

Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
by: Rachel Stading, et al.
Published: (2024-12-01)

Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome.
by: Sheng-Mou Hsiao, et al.
Published: (2016-01-01)

Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review
by: Negar Shaterian, et al.
Published: (2022-01-01)

Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy
by: Nathan Hoag, et al.
Published: (2016-03-01)

A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder
by: Laura M. Tellechea, et al.
Published: (2022-09-01)

Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder.
by: Yuan-Hong Jiang, et al.
Published: (2014-01-01)

Review of simultaneous treatment with intradetrusor onabotulinumtoxinA injections during transurethral prostate surgery for men with bladder outlet obstruction and overactive bladder
by: Chun-Kai Hsu, et al.
Published: (2025-01-01)

The Effects of Age, Gender, and Postvoid Residual Volume on Catheterization Rates After Treatment with OnabotulinumtoxinA for Overactive Bladder
by: Roger Dmochowski, et al.
Published: (2023-11-01)

Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
by: Ping-Hsuan Yu, et al.
Published: (2024-08-01)

Low dose intradetrusor injections of onabotulinumtoxinA in women with overactive bladder symptoms or the painful bladder syndrome: unfavorable balance between clinical efficacy and the need for catheterization
by: Jan Groen, et al.
Published: (2012-10-01)

Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity
by: Hyun Seok Na, et al.
Published: (2024-03-01)

Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice
by: Kwang Jin Ko, et al.
Published: (2023-05-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection
by: Jia-Fong Jhang, et al.
Published: (2015-06-01)

165 OUTCOMES OF INTRADETRUSOR INJECTION OF ONABOTULINUMTOXINA (BTX-A) FOR OVERACTIVE BLADDER IN THE ELDERLY POPULATION.
by: N Hernandez, et al.
Published: (2022-06-01)

Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury
by: Sheng-Fu Chen, et al.
Published: (2022-01-01)

Effectiveness of onabotulinumtoxin A for refractory overactive bladder with cough‐associated detrusor overactivity
by: Chie Nakai, et al.
Published: (2024-05-01)

Intravesical Loss of OnabotulinumtoxinA During Endoscopic Intradetrusor Injection - A Multicenter Experience
by: Vladimír Šámal, et al.
Published: (2020-03-01)

Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis
by: Hejia Yuan, et al.
Published: (2017-03-01)

Cognitive effects of onabotulinumtoxinA in chronic migraine
by: Natasha Bear, et al.
Published: (2020-07-01)

Efficacy of onabotulinumtoxinA treatment in episodic migraine
by: Jasem Al-Hashel, et al.
Published: (2025-01-01)

OnabotulinumtoxinA: Still the Present for Chronic Migraine
by: Carlo Baraldi, et al.
Published: (2023-01-01)

OnabotulinumtoxinA for the treatment of headache: an updated review
by: Joseph H. Talbet, et al.
Published: (2022-01-01)

Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy
by: Fabiola I. Reyes, et al.
Published: (2022-02-01)

OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients
by: García-Sáez R, et al.
Published: (2018-08-01)

Less injection points during botulinum toxin treatment for overactive bladder in the outpatient setting
by: Lidia Martín Gómez, et al.
Published: (2023-11-01)

Therapeutic Efficacy of onabotulinumtoxinA Delivered Using Various Approaches in Sensory Bladder Disorder
by: Po-Yen Chen, et al.
Published: (2020-01-01)

Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX<sup>®</sup>) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
by: Joseph Jankovic, et al.
Published: (2023-05-01)

ANATOMICAL LOCATION AND NUMBER OF INJECTION SITES OF INTRAVESICAL ONABOTULINUMTOXINA FOR FEMALES WITH REFRACTORY IDIOPATHIC OVERACTIVE BLADDER - A SYSTEMATIC SCOPING REVIEW
by: E Kelsey, et al.
Published: (2023-09-01)

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility
by: Chung-Cheng Wang, et al.
Published: (2016-03-01)

Urinary tract infections in the intradetrusor onabotulinumtoxinA population
by: Esme White, et al.
Published: (2023-04-01)

OnabotulinumtoxinA in the treatment of refractory chronic cluster headache
by: Christian Lampl, et al.
Published: (2018-06-01)

Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy
by: Liza Smirnoff
Published: (2022-08-01)

The Role of OnabotulinumtoxinA in Urology: What Is the Next Step?
by: Hong Sang Moon
Published: (2015-12-01)

OnabotulinumtoxinA in chronic migraine: is the response dose dependent?
by: Ali Zandieh, et al.
Published: (2022-06-01)

Prediction of patient's response to OnabotulinumtoxinA treatment for migraine
by: Franklin Parrales Bravo, et al.
Published: (2019-02-01)

Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
by: Tao Cheng, et al.
Published: (2016-01-01)

O’Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome
by: Yuh-Chen Kuo, et al.
Published: (2015-07-01)